NCT07822594

Brief Summary

This randomized controlled trial will investigate the immediate effects of instrument-assisted soft tissue mobilization (IASTM) performed with two different commercially available tools on posterior lower-leg tissue stiffness and ankle dorsiflexion range of motion in healthy young adults. Participants will be randomly allocated to one of three parallel groups: IASTM using a higher-cost tool, IASTM using a lower-cost tool, or passive rest without IASTM. Tissue stiffness at predefined posterior lower-leg sites and ankle dorsiflexion range of motion will be assessed before and immediately after the intervention or equivalent rest period. A single lower limb will be assessed in each participant. Participants receiving IASTM will additionally rate the pleasantness of the intervention and their perceived relaxation after the intervention. The study will determine whether IASTM produces immediate changes in tissue stiffness and ankle dorsiflexion compared with passive rest and whether these effects differ between the two IASTM tools.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Oct 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Oct 2026Jan 2027

First Submitted

Initial submission to the registry

September 10, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2027

Last Updated

September 17, 2026

Status Verified

September 1, 2026

Enrollment Period

3 months

First QC Date

September 10, 2026

Last Update Submit

September 16, 2026

Conditions

Keywords

instrument-assisted soft tissue mobilizationsoft tissue mobilizationmuscle stiffnessankle dorsiflexionMyotonPROgastrocnemiussoleusAchilles tendonrange of motion

Outcome Measures

Primary Outcomes (5)

  • Change From Baseline in Medial Gastrocnemius Stiffness

    Tissue stiffness will be measured using MyotonPRO and expressed in N/m. Two consecutive measurements will be obtained at each assessment and averaged.

    Baseline and immediately after the 6-minute intervention or rest period

  • Change From Baseline in Lateral Gastrocnemius Stiffness

    Tissue stiffness will be measured using MyotonPRO and expressed in N/m. Two consecutive measurements will be obtained at each assessment and averaged.

    Baseline and immediately after the 6-minute intervention or rest period

  • Change From Baseline in Soleus Stiffness

    Tissue stiffness will be measured using MyotonPRO and expressed in N/m. The measurement site will be located medially at one-third of the distance from the medial malleolus toward the medial femoral condyle. Two consecutive measurements will be obtained and averaged.

    Baseline and immediately after the 6-minute intervention or rest period

  • Change From Baseline in Achilles Tendon Stiffness

    Achilles tendon stiffness will be measured using MyotonPRO and expressed in N/m at a predefined site 2 cm proximal to the calcaneus. Two consecutive measurements will be obtained and averaged.

    Baseline and immediately after the 6-minute intervention or rest period

  • Change From Baseline in Ankle Dorsiflexion Range of Motion

    Ankle dorsiflexion range of motion will be measured in degrees using a digital inclinometer positioned on the lateral aspect of the lower leg during a weight-bearing lunge with the assessed knee maintained in extension and the heel in contact with the floor.

    Baseline and immediately after the 6-minute intervention or rest period

Secondary Outcomes (2)

  • Perceived Pleasantness of IASTM

    Immediately after the 6-minute IASTM intervention

  • Perceived Relaxation After IASTM

    Immediately after the 6-minute IASTM intervention

Study Arms (3)

Higher-Cost IASTM

EXPERIMENTAL

Participants will receive a standardized six-minute IASTM intervention to the posterior lower-leg region using the higher-cost IASTM tool. The first minute will include familiarization, desensitization, and application of IASTM cream, followed by five minutes of standardized treatment.

Procedure: Instrument-Assisted Soft Tissue Mobilization Using a Higher-Cost Tool

Lower-Cost IASTM

ACTIVE COMPARATOR

Participants will receive the same standardized six-minute IASTM intervention to the posterior lower-leg region using the lower-cost IASTM tool. Treatment duration, technique, instrument angle, treated region, and intensity will be matched to the higher-cost IASTM group.

Procedure: Instrument-Assisted Soft Tissue Mobilization Using a Lower-Cost Tool

Passive Control

NO INTERVENTION

Participants will rest passively for six minutes without receiving IASTM. Measurements will be performed before and immediately after the rest period using the same procedures as in the intervention groups.

Interventions

A six-minute standardized IASTM intervention applied to the posterior lower-leg region using a higher-cost IASTM tool. The first minute consists of familiarization, desensitization, and application of IASTM cream, followed by five minutes of long gliding strokes along the direction of the muscle fibers. The instrument is held at approximately 45 degrees and treatment intensity is adjusted to slight pain or moderate discomfort.

Higher-Cost IASTM

The same six-minute standardized IASTM intervention as in the higher-cost tool condition, performed using a lower-cost IASTM tool. Treatment duration, treated region, stroke direction, instrument angle, and target intensity are standardized between the two IASTM interventions.

Lower-Cost IASTM

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18 to 40 years
  • Healthy volunteer
  • Willing and able to provide written informed consent

You may not qualify if:

  • Current or previous lower-limb injury
  • Neuromuscular disorder
  • Neurological disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Primorska, Faculty of Health Sciences, Izola

Izola, Urban Municipality of Koper, 6310, Slovenia

Location

Central Study Contacts

Žiga Kozinc, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants will be randomly allocated to one of three parallel groups: higher-cost IASTM, lower-cost IASTM, or passive rest. One lower limb per participant will be assessed before and immediately after the intervention or equivalent control period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. prof. dr.

Study Record Dates

First Submitted

September 10, 2026

First Posted

September 16, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

January 15, 2027

Last Updated

September 17, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the results reported in the publication will be made available upon reasonable request. After publication of scientific manuscript, the data will also be uploaded to a trusted repository (Zenodo.org).

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data will become available following publication of the main study results and will remain available for at least 5 years.
Access Criteria
Data will be made available to researchers upon reasonable request to the corresponding author. Requests should include a brief description of the proposed analysis and intended use of the data. Data will be shared following approval by the study investigators and, where applicable, completion of an appropriate data-sharing agreement.

Locations